Skip to main content
Full access
Regular Article
Published Online: 1 May 2001

Validation of the Delirium Rating Scale-Revised-98: Comparison With the Delirium Rating Scale and the Cognitive Test for Delirium

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences

Abstract

The DRS-R-98, a 16-item clinician-rated scale with 13 severity items and 3 diagnostic items, was validated against the Cognitive Test for Delirium (CTD), Clinical Global Impression scale (CGI), and Delirium Rating Scale (DRS) among five diagnostic groups (N=68): delirium, dementia, depression, schizophrenia, and other. Mean and median DRS-R-98 scores significantly (P<0.001) distinguished delirium from each other group. DRS-R-98 total scores correlated highly with DRS, CTD, and CGI scores. Interrater reliability and internal consistency were very high. Cutoff scores for delirium are recommended based on ROC analyses (sensitivity and specificity ranges: total, 91%–100% and 85%–100%; severity, 86%–100% and 77%–93%, respectively, depending on the cutoffs or comparison groups chosen). The DRS-R-98 is a valid measure of delirium severity over a broad range of symptoms and is a useful diagnostic and assessment tool. The DRS-R-98 is ideal for longitudinal studies.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 229 - 242
PubMed: 11449030

History

Published online: 1 May 2001
Published in print: May 2001

Authors

Details

Paula T. Trzepacz, M.D.
Received February 22, 2000; accepted July 21, 2000. From the University of Mississippi Medical Center and the Sonny Montgomery Veterans Affairs Medical Center, Jackson, Mississippi; and the Eli Lilly and Company, Neuroscience Research, U.S. Affiliate, Indianapolis, Indiana. Address correspondence to Dr. Trzepacz, Lilly Corporate Center, drop code 4133, Indianapolis, IN 46285. E-mail: [email protected].
Dinesh Mittal, M.D.
Received February 22, 2000; accepted July 21, 2000. From the University of Mississippi Medical Center and the Sonny Montgomery Veterans Affairs Medical Center, Jackson, Mississippi; and the Eli Lilly and Company, Neuroscience Research, U.S. Affiliate, Indianapolis, Indiana. Address correspondence to Dr. Trzepacz, Lilly Corporate Center, drop code 4133, Indianapolis, IN 46285. E-mail: [email protected].
Rafael Torres, M.D.
Received February 22, 2000; accepted July 21, 2000. From the University of Mississippi Medical Center and the Sonny Montgomery Veterans Affairs Medical Center, Jackson, Mississippi; and the Eli Lilly and Company, Neuroscience Research, U.S. Affiliate, Indianapolis, Indiana. Address correspondence to Dr. Trzepacz, Lilly Corporate Center, drop code 4133, Indianapolis, IN 46285. E-mail: [email protected].
Kim Kanary, B.S.
Received February 22, 2000; accepted July 21, 2000. From the University of Mississippi Medical Center and the Sonny Montgomery Veterans Affairs Medical Center, Jackson, Mississippi; and the Eli Lilly and Company, Neuroscience Research, U.S. Affiliate, Indianapolis, Indiana. Address correspondence to Dr. Trzepacz, Lilly Corporate Center, drop code 4133, Indianapolis, IN 46285. E-mail: [email protected].
John Norton, M.D.
Received February 22, 2000; accepted July 21, 2000. From the University of Mississippi Medical Center and the Sonny Montgomery Veterans Affairs Medical Center, Jackson, Mississippi; and the Eli Lilly and Company, Neuroscience Research, U.S. Affiliate, Indianapolis, Indiana. Address correspondence to Dr. Trzepacz, Lilly Corporate Center, drop code 4133, Indianapolis, IN 46285. E-mail: [email protected].
Nita Jimerson, M.S.N.
Received February 22, 2000; accepted July 21, 2000. From the University of Mississippi Medical Center and the Sonny Montgomery Veterans Affairs Medical Center, Jackson, Mississippi; and the Eli Lilly and Company, Neuroscience Research, U.S. Affiliate, Indianapolis, Indiana. Address correspondence to Dr. Trzepacz, Lilly Corporate Center, drop code 4133, Indianapolis, IN 46285. E-mail: [email protected].

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share